TheraRadar
← Back
Data updated: May 24, 2026

AJANTA PHARMA LTD

Generics

AJANTA PHARMA LTD is a generic drug manufacturer focused on Neurology, Cardiovascular, Infectious Disease.

2011
Since
63
Drugs
-
Trials
2
New Drugs (2yr)
Modality:

Key Drugs

Top revenue-generating and strategically important drugs approved in the last 15 years. These represent the company's core commercial portfolio.

Therapeutic Areas

Disease areas where this company has approved drugs and active pipeline. Weighted by commercial stage: approved drugs count most, followed by late-stage trials.

Neurology 41%
9 drugs
Cardiovascular 23%
5 drugs
Infectious Disease 14%
3 drugs
Gastroenterology 14%
3 drugs
Ophthalmology 9%
2 drugs

Pipeline Snapshot

Active clinical trials across all therapeutic areas. Data from ClinicalTrials.gov.

No active pipeline data available

Pro Intelligence Preview

Deep insights for investors and analysts

Revenue Insights

  • NAPROXEN AND ESOMEPRAZOLE MAGNESIUM leads revenue
  • 3 key drugs tracked

Trial Catalysts

  • Neurology pipeline focus
  • Phase 3 readout tracking

Patent Risk

  • Patent expiration timeline
  • Revenue at risk analysis

Compare Companies

  • Side-by-side pipeline analysis
  • Revenue & market share comparison
Unlock Full Intelligence

Revenue forecasts • Trial milestones • Patent risk modeling